Genetic cholestatic liver diseases: The example of progressive familial intrahepatic cholestasis and related disorders

Acta Gastro-Enterologica Belgica

Volumn 67, Issue 2, 2004, Pages 179-183

  Baussan, C ^a   Cresteil, D ^a   Gonzales, E ^a   Raynaud, N ^a   Dumont, M ^b   Bernard, O ^a   Hadchoue, M ^a   Jacquemin, Emmanuel ^a  

^a BICÊTRE HOSPITAL   (France)

^b BEAUJON HOSPITAL   (France)

Author keywords

Children; Genetic cholestasis; PFIC

Indexed keywords

4BETA HYDROXY C27 STEROID DEHYDROGENASE ISOMERASE; ADENOSINE TRIPHOSPHATASE; ALPHA 1 ANTITRYPSIN; BILE ACID; BILE ACID COENZYME A; BILE ACID CONJUGATE; BILE SALT; DELTA4 3 OXO 5BETA,DELTA4 3 OXOSTEROID 5BETA REDUCTASE; GAMMA GLUTAMYLTRANSFERASE; ISOMERASE; MULTIDRUG RESISTANCE PROTEIN 3; OXYGENASE; OXYSTEROL 7ALPHA HYDROXYLASE; RADIXIN; STEROID 5BETA REDUCTASE; TIGHT JUNCTION PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID; VILLIN;

AAGENAES SYNDROME; ALAGILLE SYNDROME; ALPHA 1 ANTITRYPSIN DEFICIENCY; AUTOSOMAL RECESSIVE DISORDER; BILE ACID SYNTHESIS; BILE SECRETION; CHILDHOOD DISEASE; CONFERENCE PAPER; CYSTIC FIBROSIS; GENETIC DISORDER; HUMAN; INDIAN CHILDHOOD CIRRHOSIS; INTRAHEPATIC CHOLESTASIS; LIVER FAILURE; NORTH AMERICA; PATHOGENESIS; PHENOTYPE; PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS; SCLEROSING CHOLANGITIS;

CHILD; CHOLESTASIS, INTRAHEPATIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS;

EID: 3042758852     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (48)

1. SOKOL R.J., FERANCHAK A.P. Foreword. In: Genetic and metabolic basis of pediatric liver diseases. Semin. Liv. Dis., 2001, 21: 469-70.
2. JACQUEMIN E. Progressive familial intrahepatic cholestasis: genetic basis and treatment. In: Pediatric liver. Clin. Liver Dis., 2000; 4: 753-63.
3. THOMPSON R., STRAUTNIEKS S. BSEP: function and role in progressive familial intrahepatic cholestasis. Semin. Liv. Dis., 2001; 21: 545-50.
4. VAN MIL S.W.C., KLOMP L., BULL L. et al. FIC1 disease: A spectrum of intrahepatic cholestatic disorders. Semin. Liv. Dis., 2001; 21: 535-44.
5. JACQUEMIN E. Role of multidrug resistance 3 deficiency in pediatric and adult liver disease: one gene for three diseases. Semin. Liv. Dis., 2001; 21: 551-62.
6. BALISTRERI W.F. Inborn errors of bile acid biosynthesis and transport: Novel form of metabolic liver diseases. Gastroenterol. Clin. North Ant. 1999; 28: 145-72.
7. BULL L.N., VAN EIJK M.J.T., PAWLIKOWSKA L. et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat. Genet., 1998; 18: 219-24.
8. KLOMP L.W.J., BULL L.N., KNISELY A.S. et al. A missense mutation in FIC1 is associated with greenland familial cholestasis. Hepatology. 2000; 32: 1337-41.
9. UJHAZY P., ORTIZ D., MISRA S. et al. Familial intrahepatic cholestasis 1: studies of localization and function. Hepatology, 2001; 34: 768-75.
10. EPPEN E.F., VAN MIL S.W., DE VREE J.M. et al. FIC1, the protein affected in two forms of hereditary cholestasis, is localized in the cholangiocyte and the canalicular membrane of the hepatocyte. J. Hepatol., 2001; 35: 436-43.
11. BULL L.N., CARLTON V.E.H., STRICKER N.L. et al. Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): Evidence for heterogeneity. Hepatology, 1997; 26: 155-64.
12. LYKAVIERIS P., VAN MIL S., CRESTEIL D. et al. Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: no catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation. J. Hepatol., 2003; 39: 447-52.
13. EGAWA H., YORIFUJI T., SUMAZAKI R. et al. Intractable diarrhea after liver transplantation for Byler's disease: successful treatment with bile adsorptive resin. Liver Transplant, 2002; 8: 714-6.
14. PAWLIKOWSKA L., OTTENHOFF R., LOOIJE N. et al. FIC1 mutant mice have a defect in the regulation of intestinal bile salt absorption. Hepatology, 2001; 34: 240A.
15. STRAUTNIEKS S.S., BULL L.N., KNISELY A.S. et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat. Genet., 1998; 20: 233-8.
16. JANSEN P.L.M., STRAUTNIEKS S.S., JACQUEMIN E. et al. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology, 1999; 117: 1370-9.
17. WANG R., SALEM M., YOUSEF I.M. et al. Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis. Proc. Natl. Acad. Sci. USA, 2001; 98: 2011-6.
18. CHEN H.L., CHANG P.S., HSU H.C. et al. FIC1 and BSEP defects in taiwanese patients with chronic intrahepatic cholestasis with low gamma- glutamyltranspeptidase levels. J. Pediatr., 2002; 140: 119-24.
19. DELEUZE J.F., JACQUEMIN E., DUBUISSON C. et al. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology, 1996; 23: 904-8.
20. DE VREE J.M.L., JACQUEMIN E., STURM E. et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc. Natl. Acad. Sci. USA, 1998; 95: 282-7.
21. JACQUEMIN E., DE VREE J.L.M., CRESTEIL D. et al. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology. 2001; 120: 1448-58.
22. CHEN H.L., CHANG P.S., HSU H.C. et al. Progressive familial intrahepatic cholestasis with high γ-glutamyltranspeptidase levels in taiwanese infants: role of MDR3 gene defect? Pediatr Res., 2001; 50: 50-5.
23. SMIT J.J.M., SHINKEL A.H., OUDE ELFERINK R.P.J. et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell, 1993; 75: 451-62.
24. JACQUEMIN E., CRESTEIL D., MANOUVRIER S. et al. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet, 1999; 353: 210-1.
25. DIXON P.H., WEERASEKERA N., LINTON K.J. et al. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum. Mol. Genet., 2000; 9: 1209-17.
26. ROSMORDUC O., HERMELIN B., POUPON R. MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology, 2001; 120: 1459-67.
27. LUCENA J.F., HERRERO J.I., QUIROGA J. et al. A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis. Gastroenterology, 2003; 124: 1037-42.
28. GENDROT C., BACQ Y., BRECHOT M.C. et al. A second heterozygous MDR3 nonsense mutation associated with intrahepatic cholestasis of pregnancy. J Med. Genet., 2003; 40: e32(http: //www.jmedgenet.com/cgi/ content/full/40/3/e32).
29. MÜLLENBACH R., LINTON K.J., WILTSHIRE S. et al. ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy. J. Med. Genet., 2003; 40: e70(http: //wwwjmedgenet.com/cgi/content/ful)/ 40/3/e32).
30. GANNE-CARRIE N., BAUSSAN C., GRANDO V. et al. Progressive familial intrahepatic cholestasis type 3 revealed by oral contraceptive pills. J. Hepatol., 2003; 38: 693-4.
31. DE VREE J.M.L., OTTENHOFF R., BOSMA P.J. et al. Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology, 2000; 119: 1720-30.
32. CHENG J.B., JACQUEMIN E., GERHARDT M. et al. Molecular genetics of 3β-hydroxy-Δ5-C27-steroid oxidoreductase deficiency in 16 patients with loss of bile acid synthesis and liver disease. J. Clin. Endocrinol. Metab., 2003; 88: 1833-41.
33. LEMONDE H.A., CUSTARD E.J., BOUQUET J. et al. Mutations in SRD5B1 (AKR1D1), the gene encoding Delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy. Gut, 2003; 52: 1494-9.
34. 4-3-oxosteroid 5β-reductase deficiency: evidence for primary genetic defect. J. Hepatol., 2004; 40: 716-8.
35. SETCHELL K.D.R., SCHWARZ M., O'CONNELL N.C. et al. Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7 ?-hydroxylase gene causes severe neonatal liver disease. J. Clin. Invest., 1998; 102: 1690-1703.
36. BULL L.N., ROCHE E., SONG E.J. et al. Mapping of the locus for cholestasis-lymphedema syndrome (Aagenes syndrome) to a 6.6 cM interval on chromosome 15q. Am. J. Hum. Genet., 2000; 67: 994-9.
37. FRÜHWIRTH M., JANECKE A.R., MÜLLER T. et al. Evidence for genetic heterogeneity in lymphedema-cholestasis syndrome. J. Pediatr., 2003; 142: 441-7.
38. MORTON D.H., SALEN G., BATTA A.K. et al. Abnormal hepatic sinusoidal bile acid transport in an amish kindred is not linked to FIC1 and is improved by ursodiol. Gastroenterology, 2000; 119: 188-95.
39. CARLTON V.E.H., HARRIS B.Z., PUFFENBERGER E.G. et al. Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT. Nat. Genet., 2003; http://www.nature.com/naturegenetics.
40. CHAGNON P., MICHAUD J., MITCHELL G. et al. A missense mutation (R565W) in cirhin (FLJ14728) in north american indian childhood cirrhosis. Am. J. Hum. Genet., 2002; 71: 1443-9.
41. COLEMAN R.A., VAN HOVE J.L., MORRIS C.R. et al. Cerebral defects and nephrogenic diabetes insipidus with the ARC syndrome: additional findings or a new syndrome (ARCC-NDI)? Am. J. Hum. Genet., 1997; 72: 335-8.
42. MARCUS N., TECKMAN J.H., PERLMUTER D.H. al-antitrypsin deficiency: from genotype to childhood disease. J. Pediatr. Gastroenterol. Nutr., 1998; 27: 65-74.
43. FERANCHAK A.P., SOKOL R.J. Cholangiocyte biology and cystic fibrosis liver disease. Semin. Liv. Dis., 2001; 21: 471-88.
44. BAALA L., HADJI-RABIA S., HAMEL-TEILLAC D. et al. Homozygosity mapping of a locus for a novel syndromic ichthyosis to chromosome 3q27-q28. J. Invest. Dermatol., 2002; 119: 70-6.
45. JACQUEMIN E., CRESTEIL D., RAYNAUD N. et al. CFC1 gene mutation and biliary atresia with polysplenia syndrome. J. Pediatr. Gastroenterol. Nutr., 2002; 34: 326-7.
46. SCHÖN P., TSUCHIYA K., LENOIR D. et al. Identification, genomic organization, chromosomal mapping and mutation analysis of the human INV gene. the ortholog of a murine gene implicated in left-right axis development and biliary atresia. Hum. Genet., 2002; 110: 157-65.
47. PHILLIPS M.J., AZUMA T., MEREDITH S.L.M. et al. Abnormalities in villin gene expression and canalicular microvillus structure in progressive cholestatic liver disease of childhood. Lancet. 2003; 362: 1112-19.
48. KIKUCHI S., HATA M., FUKUMOTO K. et al. Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes. Nat. Genet., 2002; 31: 320-5.